The following is a listing of media impressions from research supported by the Indiana Clinical and Translational Sciences Institute or its research team members.
- Clinical Gastroenterology and Hepatology Publishes Data Showing Exact Sciences’ Oncoguard™ Liver Liquid Biopsy Test Delivers Enhanced Performance for Early-stage Detection of Hepatocellular Carcinoma – BioSpace
- Study highlights Exact Sciences’ blood test for liver cancer; MCW getting $2.7 million grant for research effort – WISBusiness
- Questions and answers on Biden’s new booster shot plan – The Hill
- Oncoguard Liver Liquid Biopsy Proves Effective in HCC Detection – Targeted Oncology
- IU professors explain legal, public health reasons for Supreme Court vaccine mandate decision – Indiana Daily Student
- Biden to Require Vaccination of All Nursing Home Workers – Healthcare Innovation
- What qualifies as an exemption to COVID-19 vaccine? – FOX 59 TV
- Local Experts Debunk Common Misconceptions About The COVID-19 Vaccination – Indiana Public Media
- Mask Research – WFYI All IN Radio
- Answering Your COVID Questions: Do Break Through Cases Mean The Vaccine Doesn’t Work? – Indiana Public Media
- IU-led Study Helps Cystic Fibrosis Patients Lighten Treatment Load – Inside Indiana Business
- IU Ventures Invests $475K in Health, Tech Companies – Inside Indiana Business
- Is it COVID, RSV, allergies or a common cold? Here’s what you need to know – IndyStar
- Doctor breaks down rigorous FDA approval process – WISH 8 TV
- We’ve Never Protected the Vulnerable – The Atlantic
